SANTA BARBARA, Calif.–(BUSINESS WIRE)–Institution Labs Holdings Inc. (NASDAQ: ESTA), a medical expertise firm targeted on ladies’s well being, initially within the breast aesthetics and reconstruction market, right now introduced that CEO and Founder Juan José Chacón-Quirós and Chief Monetary Officer Renee Gaeta will take part within the BTIG Digital MedTech, Digital Well being, Life Science and Diagnostic Instruments Convention, which is being held February 17-19, 2021. Mr. Chacón-Quirós and Mrs. Gaeta are scheduled to talk to convention attendees at 10:00 am ET on Friday, February 19, 2021.
A dwell webcast of the presentation can be accessible to all events on the Institution Labs investor relations web site at https://investors.establishmentlabs.com/. An archived model of the webcast can be accessible on the identical web site following the completion of the occasion.
About Institution Labs
Institution Labs Holdings Inc. is a world medical expertise firm targeted on ladies’s well being, initially within the breast aesthetics and reconstruction market, by designing, growing, manufacturing and advertising and marketing an revolutionary portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at our two manufacturing websites which might be compliant with ISO13485:2016, FDA 21 CFR 820 beneath the MDSAP program, and are at the moment commercially accessible in additional than 80 nations via unique distributors or the Firm’s direct salesforce. In March 2018, Institution Labs acquired approval for an investigational system exemption (IDE) from the FDA and initiated the Motiva Implant® scientific trial in america in April 2018. Along with Motiva Implants®, Institution Labs’ product and applied sciences portfolio contains the Divina® 3D Simulation System and different services and products. Please go to our web site for added data at www.establishmentlabs.com.
— to www.businesswire.com